The eye-light device, distributed in Australia by Ophthalmopro, has been granted CE medical device classification approval for the treatment of dry age-related macular degeneration

Approximately 50 families scattered across the world share ultra-rare variants in a particular gene. Silent for years, the inherited mutations cause changes in vision

After a successful inaugural global event in 2023, September has once again been declared Myopia Action Month by Australian-based Myopia Profile.

I’m thrilled to to introduce you to the 2024 myopia special edition of mivision. A smorgasbord of topics, from efficacy to effective management awaits